Abstract

BackgroundMultiple sclerosis (MS) is driven by the interaction between genetic susceptibility and environmental triggers, particularly to Epstein-Barr virus (EBV) infection. EBV-encoded microRNAs (miRNAs) are abundantly expressed in all stages of EBV infection and latency, which can target both viral and host cellular mRNAs, allowing EBV-infected B cells to evade the host immune response. However, it remains a big gap to understand the roles of EBV miRNAs and their target genes in MS pathogenesis. MethodsWe investigated the correlation between MS-related viruses infection and MS risk quantitatively by systematic analysis. All MS-related genes in B cells were obtained by integrating MS susceptibility genes and differentially expressed genes from B cells. In comparison with differentially expressed genes from B cells after EBV infection in vitro, we confirmed EBV-regulated, MS-related genes. Subsequently, we obtained target EBV miRNAs which can regulate these genes from several online databases. By constructing pathway-pathway, pathway-gene and protein-protein interaction networks, we further screened out MS-related genes and risk pathways regulated by EBV miRNAs. Finally, we identified target EBV miRNAs which may directly regulate MS-related genes through bioinformatic prediction. ResultsEBV infection showed the strongest correlation with MS risk. A total of 568 MS-related genes and 80 risk pathways in B cells were obtained. We then identified 112 MS-related genes and 18 associated risk pathways that EBV was involved in. In addition, 33 human target genes regulated by 33 EBV miRNAs overlapped with EBV-regulated, MS-related genes. Finally, 15 target EBV miRNAs and their regulated, 7 MS-related genes (MALT1, BCL10, IFNGR2, STAT3, CXCR4, PTK2B and FOXP1) have been confirmed as crucial pathogenic molecules, which could promote the initiation and development of MS through NF-kappa B (MALT1 and BCL10) and PD-L1/PD-1 (IFNGR2 and STAT3) pathways. Surprisingly, ebv-miR-BHRF1-2-5p directly targeting MALT1 was confirmed by our experiments, and FOXP1 was identified as a target gene of ebv-miR-BART11. ConclusionsThis work identified the target EBV miRNAs and their regulated, MS-related genes as well as risk pathways, which may provide a novel insight into discovering diagnostic biomarkers and therapeutic targets for MS.

Highlights

  • Multiple sclerosis (MS) is driven by the interaction between genetic susceptibility and environmental triggers, to Epstein-Barr virus (EBV) infection

  • This work identified the target EBV miRNAs and their regulated, MS-related genes and risk pathways, which may provide a novel insight into discovering diagnostic biomarkers and therapeutic targets for MS

  • After Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, we found that MS-related genes in B cells were mainly mapped into immune signaling pathways, including T helper type 17 (Th17) cell differentiation, EpsteinBarr virus infection, janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway and NF-kappa B (NF-κB) signaling pathway

Read more

Summary

Introduction

Multiple sclerosis (MS) is driven by the interaction between genetic susceptibility and environmental triggers, to Epstein-Barr virus (EBV) infection. Multiple sclerosis (MS) is an autoimmune disease characterized by demyelination of white matter in the central nervous system (CNS). It is a major cause of serious physical disability in young adults in developed countries[1]. MS involves the interaction between genetic susceptibility and environmental risk factors, and more than 200 gene loci related to MS have been identified through genome wide association studies (GWAS), which can account for 25% of the perceived heritability of MS[2,3,4]. EBV infection has been identified as a key regulator in the initiation and progress of MS, but its roles in the pathogenesis of MS have not been established

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call